Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity
Peter X. Shaw, … , Gregg J. Silverman, Joseph L. Witztum
Peter X. Shaw, … , Gregg J. Silverman, Joseph L. Witztum
Published June 15, 2000
Citation Information: J Clin Invest. 2000;105(12):1731-1740. https://doi.org/10.1172/JCI8472.
View: Text | PDF
Article

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

  • Text
  • PDF
Abstract

The immune response to oxidized LDL (OxLDL) may play an important role in atherogenesis. Working with apoE-deficient mice, we isolated a panel of OxLDL-specific B-cell lines that secrete IgM Abs that specifically bind to oxidized phospholipids such as 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC). These Abs block uptake of OxLDL by macrophages, recognize similar oxidation-specific epitopes on apoptotic cells, and are deposited in atherosclerotic lesions. The Abs were found to be structurally and functionally identical to classic “natural” T15 anti-PC Abs that are of B-1 cell origin and are reported to provide optimal protection from virulent pneumococcal infection. These findings suggest that there has been natural selection for B-1 cells secreting oxidation-specific/T15 antibodies, both for their role in natural immune defense and for housekeeping roles against oxidation-dependent neodeterminants in health and disease.

Authors

Peter X. Shaw, Sohvi Hörkkö, Mi-Kyung Chang, Linda K. Curtiss, Wulf Palinski, Gregg J. Silverman, Joseph L. Witztum

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
The DNA sequences and VDJ splice sites of the somatic VH rearrangements ...
The DNA sequences and VDJ splice sites of the somatic VH rearrangements expressed in the EO6 B-cell hybridoma and the T(EPC)15 plasmacytoma, and their relationship to the most homologous germ-line (GL) VH, DH, and JH gene segments. Sequence analysis for the 372 encoding nucleotides of the EO6 VH rearrangement did not reveal a single nucleotide variation suggestive of somatic hypermutation. The canonical T15/EO6 VDJ rearrangement has been described as an archetype for primary homology-directed recombination, which more frequently occurs during B-lymphogenesis in the fetal liver. CDR: complementarity-determining region.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts